tiprankstipranks
Altimmune Inc (ALT)
NASDAQ:ALT
US Market

Altimmune (ALT) Income Statement

Compare
3,164 Followers

Altimmune Income Statement

Last quarter (Q4 2024), Altimmune's total revenue was $5.00K, a decrease of -86.49% from the same quarter last year. In Q4, Altimmune's net income was $-23.18M. See Altimmune’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 20.00K$ 426.00K$ -68.00K$ 4.41M$ 8.19M
Gross Profit
$ 20.00K$ -51.00K$ -136.00K$ 3.86M$ -25.32M
Operating Expenses
$ 103.19M$ 96.36M$ 87.67M$ 89.95M$ 62.98M
Depreciation and Amortization
$ 238.00K$ 477.00K$ 500.00K$ 551.30K$ 298.06K
EBITDA
$ -94.81M$ -87.94M$ -84.40M$ -96.53M$ -54.15M
Operating Income
$ -103.17M$ -95.93M$ -87.74M$ -96.91M$ -54.80M
Other Income/Expenses
$ 8.11M$ 7.48M$ 2.83M$ -176.82K$ 337.24K
Pretax Income
$ -95.06M$ -88.45M$ -84.91M$ -97.09M$ -54.46M
Net Income
$ -95.06M$ -88.45M$ -84.71M$ -96.17M$ -49.04M
Per Share Metrics
Basic EPS
$ -1.34$ -1.66$ -1.81$ -2.33$ -1.91
Diluted EPS
$ -1.34$ -1.66$ -1.81$ -2.33$ -1.91
Weighted Average Shares Outstanding
71.00M 53.25M 46.93M 41.28M 25.64M
Weighted Average Shares Outstanding (Diluted)
71.00M 53.25M 46.93M 41.28M 25.64M
Currency in USD

Altimmune Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis